Intravenous immunoglobulin for severe protracted pediatric Guillain–Barre syndrome: Is single dose adequate?
Main Authors: | Priyanka Madaan, Prashant Jauhari, N M Shruthi, Biswaroop Chakrabarty, Sheffali Gulati |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Annals of Indian Academy of Neurology |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2019;volume=22;issue=1;spage=123;epage=124;aulast=Madaan |
Similar Items
-
Stroke as an initial manifestation of thiamine-responsive megaloblastic anemia
by: Priyanka Madaan, et al.
Published: (2020-01-01) -
Pharmacokinetics of Intravenous Immunoglobulin and Outcome of Guillain-Barre Syndrome
by: J Gordon Millichap
Published: (2010-01-01) -
Imunoglobulina endovenosa em crianças com síndrome de Guillain-Barré Intravenous immunoglobulin in children with Guillain-Barré syndrome
by: ISAC BRUCK, et al.
Published: (2000-12-01) -
Plasma Exchange Versus Intravenous Immunoglobulin in Children with Guillain Barré Syndrome
by: Erum Elahi, et al.
Published: (2019-12-01) -
Retreatment with intravenous immunoglobulin (IVIG) of refractory Guillain Barre syndrome in children
by: Rivas Larrauri Francisco, et al.
Published: (2014-07-01)